We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
A bipartisan group of U.S. lawmakers introduced a bill aimed at increasing the availability of over-the-counter medications to help bring down healthcare costs. Read More
AbbVie sent shockwaves through the drug industry Tuesday, announcing that it had reached a deal to acquire fellow drug giant Allergan for approximately $63 billion. Read More
Janssen’s Spravato (esketamine) spray—approved by the FDA in March for treatment-resistant depression —isn’t cost-effective at its listed price, a nonprofit drug price watchdog says. Read More
President Trump on Monday signed what he termed a “breakthrough” executive order requiring hospitals to inform patients of the prices they hash out with insurers. Read More